Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Medalist Diversified REIT A Pref | MDRRP | Nov 26, 2024 | 27.00 | +5.59 |
Medallion Bank F Pref | MBNKP | Nov 26, 2024 | 25.70 | 0.00 |
Medallion Financial | MFIN | Nov 26, 2024 | 9.46 | 0.00 |
MediaAlpha | MAX | Nov 26, 2024 | 12.73 | -1.85 |
Mediaco A | MDIA | Nov 26, 2024 | 1.63 | +23.95 |
Medical Properties Trust | MPW | Nov 26, 2024 | 4.26 | -4.91 |
MediciNova | MNOV | Nov 26, 2024 | 2.08 | +1.46 |
Medicus Pharma | MDCX | Nov 26, 2024 | 2.10 | 0.00 |
Medifast | MED | Nov 26, 2024 | 18.32 | -1.61 |
MEDIROM Healthcare Technologies ADR | MRM | Nov 26, 2024 | 3.01 | +0.67 |
MediWound | MDWD | Nov 26, 2024 | 16.90 | -2.48 |
Mednax | MD | Nov 26, 2024 | 14.75 | -0.07 |
Medpace | MEDP | Nov 26, 2024 | 335.21 | -0.77 |
Medtronic | MDT | Nov 26, 2024 | 85.68 | -0.08 |
Mega Matrix | MPU | Nov 26, 2024 | 1.69 | +9.03 |
Megacap 300 Growth Index ETF Vanguard | MGK | Nov 26, 2024 | 339.40 | +1.04 |
Megacap 300 Index ETF Vanguard | MGC | Nov 26, 2024 | 215.88 | +0.62 |
Megacap 300 Value Index ETF Vanguard | MGV | Nov 26, 2024 | 133.04 | +0.08 |
MEI Pharma | MEIP | Nov 26, 2024 | 2.84 | +2.90 |
Meihua International Medical Technologies | MHUA | Nov 26, 2024 | 0.52 | -11.44 |
MeiraGTx Holdings | MGTX | Nov 26, 2024 | 6.39 | +0.95 |
Meiwu Technology | WNW | Nov 26, 2024 | 0.96 | +13.61 |
Melar Acquisition I | MACIU | Nov 26, 2024 | 10.14 | 0.00 |
Melar Acquisition I | MACI | Nov 26, 2024 | 10.05 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Nov 26, 2024 | 5.98 | -1.48 |
MercadoLibre | MELI | Nov 26, 2024 | 2 110.00 | +0.48 |
Mercantile Bank | MBWM | Nov 26, 2024 | 50.10 | -2.03 |
Mercer International | MERC | Nov 26, 2024 | 6.14 | -4.36 |
Merchants Bancorp | MBIN | Nov 26, 2024 | 41.68 | +0.63 |
Merchants Bancorp B | MBINO | Nov 26, 2024 | 25.41 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.